Medicalgorithmics strengthens its presence in the Israeli market. The company has obtained certification for the Kardiobeat.ai patch in Israel.
The wireless patch-type heart monitoring device Kardiobeat.ai, developed and introduced globally by Medicalgorithmics, has received certification from the Israeli Ministry of Health. Approval for the use of Kardiobeat.ai in Israel strengthens the presence of the medtech company, part of the sWIG80 index, in the Israeli market and will enable the commercial implementation of the Kardiobeat.ai Holter patch for clients. The company’s management expects that once SysteMedic, Medicalgorithmics’ exclusive partner in Israel, reaches full operational scale, the company will be able to generate around PLN 5 million in annual revenue from this market starting in 2026.